Results 111 to 120 of about 7,965,138 (244)
Improvement of Sickle Cell Disease Care Mitigates the Healthcare Utilization Induced by Increased Prevalence: Experience of a Tertiary Pediatric Center
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Sickle cell disease (SCD) has undergone major changes in the last decades. Its prevalence has been steadily increasing and numerous advances have been made in the management of the disease. However, the effect in real‐life setting of these major changes is unknown, particularly in a Canadian environment. Procedure
We aimed to assess Maude Cigna, Alexia Muresan, Estelle Lecluze, Karine Leduc, Nathalie Fournier, Maria Tamer, Jean‐François Delisle, Jeremi Charbonneau, Annie Viau, Jessica Darilus, Marie‐Joëlle Doré‐Bergeron, Valérie Arsenault, Evelyne Doyon‐Trottier, Stéphanie Forte, Nancy Robitaille, Yves Pastore, Thomas Pincez +16 morewiley +1 more sourceUse of Prokinetic Agents in Adult ICU Patients: An International Inception Cohort Study (PATIENCE). [PDF]
Acta Anaesthesiol ScandCrone V, Møller MH, Granholm A, Perner A, Alhazzani W, Krogsgaard LR, Al-Fares A, Hästbacka J, Ostermann M, Pfortmueller CA, Ferrer R, Blaser AR, Wall O, Keus E, Szczeklik W, Hansen PM, Michelsen J, Bak M, Balkert LS, Severinsen T, Brøchner AC, Pedersen JE, Andreasen AS, Nielsen CT, Itenov TS, Kjær MN, Engbakken Z, Bestle MH, Hjortrup PB, Svendsen CJ, Lindkvist-Viggers S, Brand BA, Jonsson AB, Krogh TB, Jauho KR, Thomsen MS, Straarup TS, Poulsen E, Nissen CG, Breum O, Petersen PL, Torp C, Rasmussen BS, Bunzel AG, Buholzer SF, Hardman E, Törnberg D, Pérez DS, van Smaalen K, Onrust M, Maddison L, Appelberg O, Ehrlich HE, Tamme K, Juhanson R, Korjas J, Jalkanen V, Finni M, Reinikainen M, Koskue T, Czok M, Zatorski P, Doroba O, Kudlinski B, Nowak P, Bialka S, Kluzik A, Baran H, Al Duhailib Z, Hakeam HA, Alshahrani M, Elfaki OA, Alanazi FA, Aldhahri R, Belkhouja K, Alahmari A, Alsayer RM, Friman O, Balintescu A, Krag M. +79 moreeuropepmc +1 more sourceChange in Mental Health and Resilience in Childhood Cancer Survivors After Attending a Person‐Centred State‐of‐the‐Art Late Effects Clinic—on Behalf of the PanCareFollowUp Consortium
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Person‐centred follow‐up care based on evidence‐based clinical practice guidelines and providing individualised information should help to inform and reassure survivors about their medical and psychosocial situation and provide treatment and support where needed.Gisela Michel, Mieke Rijken, Marietta Kokla, Charlotte Sleurs, Jurgen Lemiere, Line Elmerdahl Frederiksen, Luzius Mader, Cecilia Follin, Sara Oberti, Jeanette Falck Winther, Selina R. van den Oever, Leontien C. M. Kremer, Helena J. H. van der Pal, Peter Spreeuwenberg, Eline Bouwman, Jeroen te Dorsthorst, Samira Essiaf, Elizabeth A. M. (Lieke) Feijen, Hannah Gsell, Riccardo Haupt, Maria van Helvoirt, Rosella P. M. G. Hermens, Lars Hjorth, Tomas Kepak, Katerina Kepakova, Anita Kienesberger, Monica Muraca, Marleen Renard, Carina Schneider, Roderick Skinner, Anne Uyttebroeck, Deveny Vanrusselt, Sabine Verschueren, Jacqueline Loonen, Saskia M. F. Pluijm, Katharina Roser, the PanCareFollowUp consortium +36 morewiley +1 more sourceBlockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer. [PDF]
Cancer DiscovSchroeder BA, Mohindroo C, Meinhardt AL, Takahashi N, Zhang Y, Lee MJ, Sahoo S, Donahue RN, Kumar R, Nirula M, Yang Y, Rastogi S, Sato N, Lee S, Tsai YT, Zhuang S, Kazi A, Huang Y, Desai P, Nichols S, Sciuto L, Pinkiert D, Chrisafis G, Greenberg M, Biery DN, Al-Marayaty R, Yang HH, Lee MP, Schultz CW, El Meskini R, Atkinson D, Fousek K, Gulley JL, Schlom J, Sato M, Shrestha RL, Sharma AK, Jolly MK, Palena C, Wakefield LM, Thomas A. +40 moreeuropepmc +1 more sourceSecretory Phospholipase A2 in Patients With Sickle Cell Disease Hospitalized for Vaso‐Occlusive Pain Episodes
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Secretory phospholipase A2 (sPLA2) is an inflammatory mediator linked to acute chest syndrome (ACS) in sickle cell disease (SCD), a serious complication that can develop during an acute vaso‐occlusive pain episode (VOE). Plasma sPLA2 levels have been proposed as a potential biomarker for predicting ACS onset.Rawan Korman, Maria Yasmine, Dunia Hatabah, Noor Alzraikat, Frank Harris, Lou Ann Brown, Satheesh Chonat, Nitya Bakshi, Chris A. Rees, Carlton Dampier, Claudia R. Morris +10 morewiley +1 more sourceDexamethasone Versus Placebo in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Study Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest Trial (DANOHCA). [PDF]
Acta Anaesthesiol ScandAndreasen JB, Grejs AM, Mölström S, Andersen LPK, Möller S, Christensen S, Schmidt H, Møller JE, Meyer MAS, Kjærgaard J, Erbs AW, Rasmussen BS, Hassager C. +12 moreeuropepmc +1 more source
